ARYA Sciences Acquisition Corp IV (ARYD)

NASDAQ: ARYD · IEX Real-Time Price · USD
0.00 (0.00%)
At close: Dec 7, 2023, 3:59 PM
+0.03 (0.27%)
After-hours: Dec 7, 2023, 4:00 PM EST
Market Cap 86.49M
Revenue (ttm) n/a
Net Income (ttm) 1.44M
Shares Out 4.19M
EPS (ttm) 0.09
PE Ratio 121.22
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 461
Open 10.90
Previous Close 10.91
Day's Range 10.90 - 10.91
52-Week Range 10.04 - 10.94
Beta -0.01
Analysts n/a
Price Target n/a
Earnings Date n/a

About ARYD

ARYA Sciences Acquisition Corp IV does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Feb 26, 2021
Country United States
Stock Exchange NASDAQ
Ticker Symbol ARYD
Full Company Profile

Financial Performance

Financial Statements


ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus' Gene Therapy Business Due to Market Conditions

NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) (“ARYA IV”), a publicly traded special purpose acquisition company sponsored by Perceptive Advisors announc...

1 year ago - GlobeNewsWire